Roth Capital Starts CymaBay Therapeutic (CBAY) at Buy
Tweet
Share
E-mailGet Alerts CBAY Hot Sheet
Price: $32.48 --0%
Rating Summary:
7 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
7 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Roth Capital initiated coverage on CymaBay Therapeutic (NASDAQ: CBAY) with a Buy rating and a price target of $14.00.
For an analyst ratings summary and ratings history on CymaBay Therapeutic click here. For more ratings news on CymaBay Therapeutic click here.
Shares of CymaBay Therapeutic closed at $7.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Resumes EQT Corp. (EQT) at Hold
- Benchmark Starts Azek Co. (AZEK) at Buy
- RBC Capital Starts Banco de Sabadell SA (SAB:SM) (BNDSF) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
